» Articles » PMID: 38937710

-Interacting Plasma Membrane Proteins and Binding Partner Identification

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2024 Jun 27
PMID 38937710
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma membrane proteins (PMPs) play critical roles in a myriad of physiological and disease conditions. A unique subset of PMPs functions through interacting with each other at the interface between two contacting cells. These -interacting PMPs (tiPMPs) include adhesion molecules and ligands/receptors that facilitate cell-cell contact and direct communication between cells. Among the tiPMPs, a significant number have apparent extracellular binding domains but remain orphans with no known binding partners. Identification of their potential binding partners is therefore important for the understanding of processes such as organismal development and immune cell activation. While a number of methods have been developed for the identification of protein binding partners in general, very few are applicable to tiPMPs, which interact in a two-dimensional fashion with low intrinsic binding affinities. In this review, we present the significance of tiPMP interactions, the challenges of identifying binding partners for tiPMPs, and the landscape of method development. We describe current avidity-based screening approaches for identifying novel tiPMP binding partners and discuss their advantages and limitations. We conclude by highlighting the importance of developing novel methods of identifying new tiPMP interactions for deciphering the complex protein interactome and developing targeted therapeutics for diseases.

References
1.
Dustin M, Bromley S, Davis M, Zhu C . Identification of self through two-dimensional chemistry and synapses. Annu Rev Cell Dev Biol. 2001; 17:133-57. DOI: 10.1146/annurev.cellbio.17.1.133. View

2.
Chen W, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N . Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease. Cell. 2020; 182(4):976-991.e19. DOI: 10.1016/j.cell.2020.06.038. View

3.
Kim D, Herr A . Protein immobilization techniques for microfluidic assays. Biomicrofluidics. 2013; 7(4):41501. PMC: 3747845. DOI: 10.1063/1.4816934. View

4.
Georganaki M, van Hooren L, Dimberg A . Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer. Front Immunol. 2019; 9:3081. PMC: 6309238. DOI: 10.3389/fimmu.2018.03081. View

5.
Rosette C, Werlen G, Daniels M, Holman P, Alam S, Travers P . The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity. 2001; 15(1):59-70. DOI: 10.1016/s1074-7613(01)00173-x. View